Susquehanna International Group, LLP Dyne Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$31.94 - $47.04 $891,126 - $1.31 Million	27,900 Added 146.84%	46,900 $1.68 Million
Q2 2024 Aug 15, 2024	SELL	$23.65 - $35.63 $2.05 Million - $3.09 Million	-86,700 Reduced 82.02%	19,000 $670,000
Q1 2024 May 07, 2024	BUY	$13.06 - $29.18 $890,692 - $1.99 Million	68,200 Added 181.87%	105,700 $3 Million
Q4 2023 Feb 14, 2024	BUY	$6.62 - $13.64 $248,250 - $511,500	37,500 New	37,500 $498,000
Q2 2023 Aug 11, 2023	BUY	$8.53 - $14.28 $102,359 - $171,360	12,000 New	12,000 $135,000

210

102M

234K

238K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.47B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.